Cargando…

Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue

AIMS: Liraglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist used as an anti-hyperglycemic agent in type 2 diabetes treatment and recently approved for obesity management. Weight loss is attributed to appetite suppression, but therapy may also increase energy expenditure. To f...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Fernanda C. B., Bauer, Eduarda J., Ribeiro, Carolina M., Pereira, Sidney A., Beserra, Bruna T. S., Wajner, Simone M., Maia, Ana L., Neves, Francisco A. R., Coelho, Michella S., Amato, Angelica A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771968/
https://www.ncbi.nlm.nih.gov/pubmed/35069450
http://dx.doi.org/10.3389/fendo.2021.803363

Ejemplares similares